Author

Meenu Priya Resmi

University of ArizonaORCID 0009-0008-6034-0169Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:imaging· 2 Assay:spatial transcriptomics· 2 Research Focus:cell type annotation· 1 Approach:deep learning· 1

Frequent Co-Authors

Jayati L. ChakrabartiiD· 2 shared Abigail G. Branch· 1 shared Elliott B. BurdetteiD· 1 shared Eugene DouglassiD· 1 shared Frédéric HollandeiD· 1 shared Gregory Lawrence BeattyiD· 1 shared Jiang Wang· 1 shared Kellen CheniD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

Jayati L. ChakrabartiORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BioengineeringbioRxivPreprintSep 7, 2026

Patient-Derived Organoids as a Model to Understand Tumor Microenvironment-Driven Nano-Bio Interactions - A Framework Towards Improved Nanomedicine Translation

Meenu Priya Resmi, Jayati L. Chakrabarti, Kelvin W. Pond, Swarna Ganesh

This paper uses patient-derived colonic organoids to study how tumor microenvironment proteins affect nanoparticle uptake and delivery, showing improved targeting of chemoresistant cells.

DOI 10.64898/2026.09.03.749195

humanspatial transcriptomics

𝕏 PostBluesky

Cancer BiologybioRxivPreprintMay 22, 2025

Spatial Biology and Organoid Technologies Reveal a Potential Therapy-Resistant Cancer Stem Cell Population in Pancreatic Ductal Adenocarcinoma

Pritha Adhikary, Jayati L. Chakrabarti, Saptarshi Mallick…·Yana L. Zavros

The paper uses spatial imaging and organoid models to identify therapy-resistant CD44v9+ cancer stem cells in PDAC and show that cabozantinib may enhance immunotherapy by altering the tumor microenvironment.

1 citation

humanspatial transcriptomics

𝕏 PostBluesky